Gabapentin for the treatment of tremor

Michele A. Faulkner; John M. Bertoni; Thomas L. Lenz; Christina Dalmady-Israel; Bruno Edouard

doi:10.1177/106002800303700222

Gabapentin for the treatment of tremor

Michele A. Faulkner, John M. Bertoni, Thomas L. Lenz, Christina Dalmady-Israel, Bruno Edouard

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Abstract

OBJECTIVE: To review the use of the antiepileptic drug gabapentin for the treatment of various types of tremor. DATA SOURCES: A search of biomedical literature was completed through MEDLINE and EMBASE (1993-May 2002) to identify all clinical trials pertaining to the use of gabapentin for the treatment of tremor in humans. DATA SYNTHESIS: Outcome data from the few published studies have varied widely. Patient groups have been small, and conclusions have been based largely on subjective patient and investigator ratings. CONCLUSIONS: A trial of gabapentin is warranted in patients who fail therapy with traditional agents. Improvement should be measured by a patient's perceived functional ability.

Original language	English (US)
Pages (from-to)	282-286
Number of pages	5
Journal	Annals of Pharmacotherapy
Volume	37
Issue number	2
DOIs	https://doi.org/10.1177/106002800303700222
State	Published - Feb 1 2003
Externally published	Yes

Keywords

Essential tremor
Gabapentin
Orthostatic tremor
Parkinsonian tremor

ASJC Scopus subject areas

Pharmacology (medical)

Access to Document

10.1177/106002800303700222

Cite this

@article{6ffb62787b704dbca0874498765b99ba,

title = "Gabapentin for the treatment of tremor",

abstract = "OBJECTIVE: To review the use of the antiepileptic drug gabapentin for the treatment of various types of tremor. DATA SOURCES: A search of biomedical literature was completed through MEDLINE and EMBASE (1993-May 2002) to identify all clinical trials pertaining to the use of gabapentin for the treatment of tremor in humans. DATA SYNTHESIS: Outcome data from the few published studies have varied widely. Patient groups have been small, and conclusions have been based largely on subjective patient and investigator ratings. CONCLUSIONS: A trial of gabapentin is warranted in patients who fail therapy with traditional agents. Improvement should be measured by a patient's perceived functional ability.",

keywords = "Essential tremor, Gabapentin, Orthostatic tremor, Parkinsonian tremor",

author = "Faulkner, {Michele A.} and Bertoni, {John M.} and Lenz, {Thomas L.} and Christina Dalmady-Israel and Bruno Edouard",

year = "2003",

month = feb,

day = "1",

doi = "10.1177/106002800303700222",

language = "English (US)",

volume = "37",

pages = "282--286",

journal = "Annals of Pharmacotherapy",

issn = "1060-0280",

publisher = "SAGE Publications Inc.",

number = "2",

}

TY - JOUR

T1 - Gabapentin for the treatment of tremor

AU - Faulkner, Michele A.

AU - Bertoni, John M.

AU - Lenz, Thomas L.

AU - Dalmady-Israel, Christina

AU - Edouard, Bruno

PY - 2003/2/1

Y1 - 2003/2/1

N2 - OBJECTIVE: To review the use of the antiepileptic drug gabapentin for the treatment of various types of tremor. DATA SOURCES: A search of biomedical literature was completed through MEDLINE and EMBASE (1993-May 2002) to identify all clinical trials pertaining to the use of gabapentin for the treatment of tremor in humans. DATA SYNTHESIS: Outcome data from the few published studies have varied widely. Patient groups have been small, and conclusions have been based largely on subjective patient and investigator ratings. CONCLUSIONS: A trial of gabapentin is warranted in patients who fail therapy with traditional agents. Improvement should be measured by a patient's perceived functional ability.

AB - OBJECTIVE: To review the use of the antiepileptic drug gabapentin for the treatment of various types of tremor. DATA SOURCES: A search of biomedical literature was completed through MEDLINE and EMBASE (1993-May 2002) to identify all clinical trials pertaining to the use of gabapentin for the treatment of tremor in humans. DATA SYNTHESIS: Outcome data from the few published studies have varied widely. Patient groups have been small, and conclusions have been based largely on subjective patient and investigator ratings. CONCLUSIONS: A trial of gabapentin is warranted in patients who fail therapy with traditional agents. Improvement should be measured by a patient's perceived functional ability.

KW - Essential tremor

KW - Gabapentin

KW - Orthostatic tremor

KW - Parkinsonian tremor

UR - http://www.scopus.com/inward/record.url?scp=0037317104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037317104&partnerID=8YFLogxK

U2 - 10.1177/106002800303700222

DO - 10.1177/106002800303700222

M3 - Article

C2 - 12549962

AN - SCOPUS:0037317104

SN - 1060-0280

VL - 37

SP - 282

EP - 286

JO - Annals of Pharmacotherapy

JF - Annals of Pharmacotherapy

IS - 2

ER -

Gabapentin for the treatment of tremor

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this